151 related articles for article (PubMed ID: 37608043)
1. Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study.
Roseau-Vincenti A; Forestier E; Lanoix JP; Ricard C; Carret MC; Caraux-Paz P; Paccalin M; Gavazzi G; Roubaud-Baudron C;
Infection; 2024 Feb; 52(1):155-163. PubMed ID: 37608043
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
[TBL] [Abstract][Full Text] [Related]
3. Appropriateness of empirical antibiotic prescription for bloodstream infections in an emergency department from 2006 to 2018: impact of the spread of ESBL-producing Enterobacterales.
Clemenceau M; Ahmed-Elie S; Vilfaillot A; Chocron R; Compain F; Lebeaux D; Grohs P
Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):71-77. PubMed ID: 34553311
[TBL] [Abstract][Full Text] [Related]
4. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital.
Lim CL; Spelman D
Infect Dis Health; 2019 Aug; 24(3):124-133. PubMed ID: 30928569
[TBL] [Abstract][Full Text] [Related]
5. Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital.
Dramowski A; Aiken AM; Rehman AM; Snyman Y; Reuter S; Grundmann H; Scott JAG; de Kraker MEA; Whitelaw A
J Glob Antimicrob Resist; 2022 Jun; 29():176-184. PubMed ID: 35283332
[TBL] [Abstract][Full Text] [Related]
6. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
Li C; Li Y; Zhao Z; Liu Q; Li B
J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant
Ruvinsky S; Voto C; Roel M; Deschutter V; Ferraro D; Aquino N; Reijtman V; Galvan ME; Motto E; García M; Sarkis C; Bologna R
Front Public Health; 2022; 10():983174. PubMed ID: 36091556
[TBL] [Abstract][Full Text] [Related]
8. Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy.
Lee YC; Hsiao CY; Hung MC; Hung SC; Wang HP; Huang YJ; Wang JT
Medicine (Baltimore); 2016 May; 95(20):e3694. PubMed ID: 27196480
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience.
Shendi AM; Wallis G; Painter H; Harber M; Collier S
Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29151282
[TBL] [Abstract][Full Text] [Related]
10. Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
Lee CH; Hsieh CC; Hong MY; Hung YP; Ko WC; Lee CC
Int J Antimicrob Agents; 2017 May; 49(5):617-623. PubMed ID: 28315452
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
Giannella M; Pascale R; Ferraro G; Toschi A; Pancaldi L; Furii F; Bartoletti M; Tedeschi S; Ambretti S; Lewis RE; Viale P
Int J Antimicrob Agents; 2019 May; 53(5):574-581. PubMed ID: 30639527
[TBL] [Abstract][Full Text] [Related]
12. Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
Russo A; Falcone M; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Cisneros JM; Hernández-Torres A; Farcomeni A; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Mora-Rillo M; Rodriguez-Gomez J; Souli M; Bonomo RA; Paterson DL; Carmeli Y; Pascual A; Rodríguez-Baño J; Venditti M;
Int J Antimicrob Agents; 2018 Nov; 52(5):577-585. PubMed ID: 29969692
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.
Ivády B; Kenesei É; Tóth-Heyn P; Kertész G; Tárkányi K; Kassa C; Ujhelyi E; Mikos B; Sápi E; Varga-Heier K; Guóth G; Szabó D
Infection; 2016 Jun; 44(3):309-21. PubMed ID: 26546372
[TBL] [Abstract][Full Text] [Related]
14. Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy.
Syue LS; Tang HJ; Hung YP; Chen PL; Li CW; Li MC; Tsai PF; Liu CC; Lee NY; Ko WC
J Microbiol Immunol Infect; 2019 Apr; 52(2):225-232. PubMed ID: 30528336
[TBL] [Abstract][Full Text] [Related]
15. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
[TBL] [Abstract][Full Text] [Related]
16. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
[TBL] [Abstract][Full Text] [Related]
17. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A;
Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672
[TBL] [Abstract][Full Text] [Related]
18. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of elderly patients with bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae in an Italian Internal Medicine ward.
Meini S; Laureano R; Tascini C; Arena F; Fani L; Frullini A; Passaleva MT; Roberts AT; Mannini D; Sbrana F; Ripoli A; Rossolini GM
Eur J Intern Med; 2018 Feb; 48():50-56. PubMed ID: 29089174
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for microbiologic failure in children with Enterobacter species bacteremia.
Boguniewicz J; Revell PA; Scheurer ME; Hulten KG; Palazzi DL
PLoS One; 2021; 16(10):e0258114. PubMed ID: 34618858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]